SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-024790
Filing Date
2023-02-06
Accepted
2023-02-06 06:08:06
Documents
13
Period of Report
2023-02-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d433069d8k.htm   iXBRL 8-K 34845
  Complete submission text file 0001193125-23-024790.txt   195409

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amam-20230206.xsd EX-101.SCH 3870
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amam-20230206_def.xml EX-101.DEF 13636
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amam-20230206_lab.xml EX-101.LAB 22565
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amam-20230206_pre.xml EX-101.PRE 14604
7 EXTRACTED XBRL INSTANCE DOCUMENT d433069d8k_htm.xml XML 5330
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 729-3339
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40505 | Film No.: 23588276
SIC: 2836 Biological Products, (No Diagnostic Substances)